BBIO position history
The shares of Bridgebio Pharma (BBIO) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 53,241,982 shares, $2.5B, 6.9% of portfolio
- 2021 Q4: 53,241,982 shares, $888M, 2.6% of portfolio
- 2022 Q1: 26,620,991 shares, $270M, 1.1% of portfolio, Reduce −50.0%
- 2022 Q2: 26,620,991 shares, $242M, 1.1% of portfolio
- 2022 Q3: 26,620,991 shares, $265M, 1.2% of portfolio
- 2022 Q4: 26,620,991 shares, $203M, 1.0% of portfolio
- 2023 Q1: 26,620,991 shares, $441M, 2.1% of portfolio
- 2023 Q2: 26,620,991 shares, $458M, 1.9% of portfolio
- 2023 Q3: 25,120,991 shares, $662M, 2.7% of portfolio, Reduce −5.6%
- 2023 Q4: 25,120,991 shares, $1B, 3.7% of portfolio
- 2024 Q1: 25,120,991 shares, $777M, 2.9% of portfolio
- 2024 Q2: 25,120,991 shares, $636M, 2.4% of portfolio
- 2024 Q3: 25,120,991 shares, $640M, 2.3% of portfolio
- 2024 Q4: 25,120,991 shares, $689M, 2.2% of portfolio
- 2025 Q1: 22,055,375 shares, $762M, 2.4% of portfolio, Reduce −12.2%
- 2025 Q2: 18,555,375 shares, $801M, 2.3% of portfolio, Reduce −15.9%
- 2025 Q3: 15,977,849 shares, $830M, 2.2% of portfolio, Reduce −13.9%
- 2025 Q4: 14,393,934 shares, $1.1B, 2.9% of portfolio, Reduce −9.9%
- 2026 Q1: 11,842,434 shares, $879M, 2.5% of portfolio, Reduce −17.7%
- 2026 Q2: 9,949,219 shares, $741M, 2.1% of portfolio, Reduce −16.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|